Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Targeting ECM disrupts cancer progression
Freja A. Venning
, Lena Wullkopf
, Janine T. Erler
Research output
:
Contribution to journal
›
Review article
›
peer-review
228
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting ECM disrupts cancer progression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Extracellular Matrix
100%
Cancer Progression
100%
Extracellular Matrix Protein 1 (ECM1)
66%
Cancer Cells
33%
Cancer Mortality
33%
Metastatic Disease
33%
Biochemical Changes
33%
Multi-step Process
33%
Preclinical Data
33%
Macromolecules
33%
Metastatic Cascade
33%
Multiple Steps
33%
Isolated Tumor
33%
Cancer Spread
33%
Biomechanical Changes
33%
Medicine and Dentistry
Extracellular Matrix
100%
Cancer Growth
100%
Malignant Neoplasm
66%
Scleroprotein
66%
Neoplasm
33%
Cancer Cell
33%
Metastatic Carcinoma
33%
Cancer Spread
33%
Nursing and Health Professions
Malignant Neoplasm
100%
Cancer Growth
100%
Scleroprotein
66%
Neoplasm
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Cancer Growth
100%
Scleroprotein
66%
Neoplasm
33%